Oncology

top of page

iPharmaCenter

News | Blogs | Healthcare | Consulting

Contact: info@ipharmacenter.com

Home
Pharma
Healthcare News
Healthcare Policies
Disease News
Conferences
Others
- COVID-19
- Contact

Search

ipharmaservices

Oct 9

Merck's Keytruda Shows Improvement in Event-Free Survival (EFS) in Perioperative Treatment for Patients with Resected Locally Advanced Head and Neck Squamous Cell Carcinoma

ipharmaservices

Aug 9

Merck's Keytruda plus vibostolimab fails to improve over Tecentriq in ES-SCLC patients | iPharmaCenter

Colorectal cancer | News | Media | Updates

ipharmaservices

Apr 13

Colorectal cancer | News | Media | Updates

Gastric cancer news | 2024 | iPharmaCenter

ipharmaservices

Jan 16

Gastric cancer news | 2024 | iPharmaCenter

Renal cell carcinoma | Kidney cancer | News | Blogs | iPharmaCenter

ipharmaservices

Nov 2, 2023

Renal cell carcinoma | Kidney cancer | News | Blogs | iPharmaCenter

Esophageal squamous cell carcinoma | News | Updates | iPharmaCenter

ipharmaservices

Sep 22, 2023

Esophageal squamous cell carcinoma | News | Updates | iPharmaCenter

NSCLC Drug Development Updates | Lung cancer news

ipharmaservices

Sep 6, 2023

NSCLC Drug Development Updates | Lung cancer news

ipharmaservices

May 4, 2023

Non-Hodgkin lymphoma news | Breyanzi efficacy in FL and MCL

Mantle Cell Lymphoma News | Blogs | iPharmaCenter

ipharmaservices

Apr 17, 2023

Mantle Cell Lymphoma News | Blogs | iPharmaCenter

Breast Cancer News | Verzenio | Kisqali | Ibrance | Enhertu | iPharmaCenter

ipharmaservices

Mar 27, 2023

Breast Cancer News | Verzenio | Kisqali | Ibrance | Enhertu | iPharmaCenter

Prostate Cancer | 2023 | News | Blogs | iPharmaCenter

ipharmaservices

Mar 19, 2023

Prostate Cancer | 2023 | News | Blogs | iPharmaCenter

Gastric Cancer | News | Blogs | iPharmaCenter

ipharmaservices

Nov 29, 2022

Gastric Cancer | News | Blogs | iPharmaCenter

Myelofibrosis | News | Blogs | Updates | GSK | iPharmaCenter

ipharmaservices

Aug 18, 2022

Myelofibrosis | News | Blogs | Updates | GSK | iPharmaCenter

Breast Cancer News | Blogs | Keytruda, Trodelvy was approved for TNBC | iPhamaCenter

ipharmaservices

Jan 17, 2022

Breast Cancer News | Blogs | Keytruda, Trodelvy was approved for TNBC | iPhamaCenter

For sponsored articles, link insertions, and advertisements, please write to info@ipharmacenter.com

Find the latest pharma and healthcare news on Telegram now. Simply scan the QR code.

Rephrase with Ginger (Cmd+⌥+E)

iPharmaCenter Telegran_edited.jpg

bottom of page